KETOPROFEN, A NONSTEROIDAL ANTIINFLAMMATORY DRUG PREVENTS THE LATE-ONSET REDUCTION OF MUSCARINIC RECEPTORS IN GERBIL HIPPOCAMPUS AFTER TRANSIENT FOREBRAIN ISCHEMIA
M. Asanuma et al., KETOPROFEN, A NONSTEROIDAL ANTIINFLAMMATORY DRUG PREVENTS THE LATE-ONSET REDUCTION OF MUSCARINIC RECEPTORS IN GERBIL HIPPOCAMPUS AFTER TRANSIENT FOREBRAIN ISCHEMIA, Neuroscience letters, 225(2), 1997, pp. 109-112
Ischemia-induced hippocampal late-onset reduction of muscarinic acetyl
choline receptors (LORMAR) begins as late as 7 days after transient fo
rebrain ischemia in the gerbil, but it precedes to completion of neuro
nal death in the CA1 region. We previously reported that post-ischemic
administration of cyclosporin A prevented LORMAR with suppression of
astroglial and microglial activation. In the present study, we showed
that the chronic post-ischemic administration of a non-steroidal anti-
inflammatory drug, ketoprofen (5 mg/kg, subcutaneously, twice a day fo
r 14 days) significantly reduced LORMAR both 14 days and 21 days after
the 5-min transient ischemia. This protective effect of ketoprofen ag
ainst LORMAR suggests that the non-steroidal anti-inflammatory drugs i
s clinically efficacious in the treatment of LORMAR, a sequela of cere
bral ischemia. (C) 1997 Elsevier Science Ireland Ltd.